PACAP-38

pituitary adenylate cyclase-activating polypeptide-38

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PACAP-38, covering 2019-01-23 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38 [NA]